Anhui Anke Buys Company with a Hepatitis B Drug

Anhui Anke Biotechnology paid 7 million RMB ($1 million) for a 70% stake in Zhejiang Fuwei Pharmaceutical. Fuwei’s major product is adefovir dipivoxil, an oral nucleotide analog reverse transcriptase inhibitor (ntRTI), used to treat hepatitis B. More details... Stock Symbol: (SZEX: 300009)